Document Detail


Antihypertensive drugs and endothelial cell function.
MedLine Citation:
PMID:  8992496     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Arterial hypertension is associated with increased capillary permeability, a possible contributor to the vascular remodeling process which could be involved in certain pathological conditions arising from elevated blood pressure. This study evaluated the effects of various antihypertensive drugs on capillary permeability in the normal rat, using Evan's blue dye (EB) as a marker of albumin extravasation. The results reveal that acute injection of certain diuretics (furosemide, indapamide, hydrochlorothiazide) increase while others (amiloride, cicletanine) decrease capillary permeability via stimulation of the cyclooxygenase pathway. 10 day gavage with indapamide, amiloride and cicletanine, as well as angiotensin-converting enzyme (ACE) inhibitor perindopril and calcium channel blockers nifedipine and verapamil decreases capillary permeability, whereas furosemide, hydrochlorothiazide, ACE inhibitor captopril and calcium channel blocker clentiazem do not modify or increase EB extravasation. Hence, selected antihypertensive agents reduce capillary permeability and could therefore have a supplemental protective vascular effect, in addition to their lowering arterial pressure.
Authors:
S Lehoux; G E Plante
Related Documents :
7026256 - Haemodynamic profile of captopril treatment in various forms of hypertension.
7850666 - Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute hear...
3555586 - Captopril + hydrochlorothiazide 24 h ambulatory monitoring effects.
8891746 - Induction of cardiac angiotensinogen mrna and angiotensin converting enzyme (ace) activ...
3139616 - Accelerated decay of inspiratory pressure during hypercapnic endurance trials in humans.
23369596 - The use of negative-pressure therapy in the closure of complex head and neck wounds.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Prostaglandins, leukotrienes, and essential fatty acids     Volume:  54     ISSN:  0952-3278     ISO Abbreviation:  Prostaglandins Leukot. Essent. Fatty Acids     Publication Date:  1996 Jan 
Date Detail:
Created Date:  1997-01-14     Completed Date:  1997-01-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8802730     Medline TA:  Prostaglandins Leukot Essent Fatty Acids     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  65-70     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Québec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Animals
Antihypertensive Agents / pharmacology*
Calcium Channel Blockers / pharmacology
Capillary Permeability / drug effects*
Coloring Agents
Diuretics / pharmacology
Endothelium, Vascular / drug effects*,  physiology
Enzyme Activation / drug effects
Evans Blue
Indomethacin / pharmacology
Prostaglandin-Endoperoxide Synthases / metabolism
Rats
Serum Albumin
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 0/Coloring Agents; 0/Diuretics; 0/Serum Albumin; 314-13-6/Evans Blue; 53-86-1/Indomethacin; EC 1.14.99.1/Prostaglandin-Endoperoxide Synthases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in human...
Next Document:  Antihypertensive therapy and wave reflections.